カテゴリー： 世界, 医療/バイオ, LP Information

世界の構造的心疾患介入療法市場予測 2023年-2029年

【英語タイトル】Global Structural Heart Disease Interventional Therapy Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC04733）・商品コード：LP23DC04733
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の構造的心疾患介入療法市場」は、過去の販売実績から2022年の世界の構造的心疾患介入療法の総販売量を検討し、2023年から2029年の予測される構造的心疾患介入療法の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の構造的心疾患介入療法の市場規模を掲載し、XXX百万米ドル規模の世界の構造的心疾患介入療法市場の詳細な分析を提供します。本インサイトレポートは、世界の構造的心疾患介入療法業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の構造的心疾患介入療法市場における各社の独自のポジションをより深く理解するために、構造的心疾患介入療法製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の構造的心疾患介入療法市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。構造的心疾患介入療法の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。構造的心疾患介入療法の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。構造的心疾患介入療法のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

構造的心疾患介入療法の世界主要メーカーとしては、Abbott Structural Heart、 philips、 Japen Lifeline、 Neovasc、 Append Medical、 Transverse Medical、 Cardiomech、 Thubrikar Aortic Valve Inc.、 boston scientific、 Edwards Lifesciences Corporation、 Biomerics、 LivaNova PLCなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の構造的心疾患介入療法市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では構造的心疾患介入療法市場をセグメンテーションし、種類別 (装備品、消耗品)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：装備品、消耗品

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の構造的心疾患介入療法市場の10年間の市場状況・展望は？
・世界および地域別に見た構造的心疾患介入療法市場成長の要因は何か？
・構造的心疾患介入療法の市場機会はエンドマーケットの規模によってどのように変化するのか？
・構造的心疾患介入療法のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：構造的心疾患介入療法の年間販売量2018-2029、地域別現状・将来分析
・構造的心疾患介入療法の種類別セグメント：装備品、消耗品
・構造的心疾患介入療法の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・構造的心疾患介入療法の用途別セグメント：病院、診療所、その他
・構造的心疾患介入療法の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の構造的心疾患介入療法市場
・企業別のグローバル構造的心疾患介入療法市場データ：2018-2023年の年間販売量、市場シェア
・企業別の構造的心疾患介入療法の年間売上：2018-2023年の売上、市場シェア
・企業別の構造的心疾患介入療法販売価格
・主要企業の構造的心疾患介入療法生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

構造的心疾患介入療法の地域別レビュー
・地域別の構造的心疾患介入療法市場規模2018-2023：年間販売量、売上
・主要国別の構造的心疾患介入療法市場規模2018-2023：年間販売量、売上
・南北アメリカの構造的心疾患介入療法販売の成長
・アジア太平洋の構造的心疾患介入療法販売の成長
・ヨーロッパの構造的心疾患介入療法販売の成長
・中東・アフリカの構造的心疾患介入療法販売の成長

南北アメリカ市場
・南北アメリカの国別の構造的心疾患介入療法販売量、売上（2018-2023）
・南北アメリカの構造的心疾患介入療法の種類別販売量
・南北アメリカの構造的心疾患介入療法の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の構造的心疾患介入療法販売量、売上（2018-2023）
・アジア太平洋の構造的心疾患介入療法の種類別販売量
・アジア太平洋の構造的心疾患介入療法の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の構造的心疾患介入療法販売量、売上（2018-2023）
・ヨーロッパの構造的心疾患介入療法の種類別販売量
・ヨーロッパの構造的心疾患介入療法の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の構造的心疾患介入療法販売量、売上（2018-2023）
・中東・アフリカの構造的心疾患介入療法の種類別販売量
・中東・アフリカの構造的心疾患介入療法の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・構造的心疾患介入療法の製造コスト構造分析
・構造的心疾患介入療法の製造プロセス分析
・構造的心疾患介入療法の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・構造的心疾患介入療法の主要なグローバル販売業者
・構造的心疾患介入療法の主要なグローバル顧客

地域別の構造的心疾患介入療法市場予測レビュー
・地域別の構造的心疾患介入療法市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・構造的心疾患介入療法の種類別市場規模予測
・構造的心疾患介入療法の用途別市場規模予測

主要企業分析
Abbott Structural Heart、 philips、 Japen Lifeline、 Neovasc、 Append Medical、 Transverse Medical、 Cardiomech、 Thubrikar Aortic Valve Inc.、 boston scientific、 Edwards Lifesciences Corporation、 Biomerics、 LivaNova PLC
・企業情報
・構造的心疾患介入療法製品
・構造的心疾患介入療法販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Structural Heart Disease Interventional Therapy market size is projected to grow from US$ 13240 million in 2022 to US$ 27840 million in 2029; it is expected to grow at a CAGR of 11.2% from 2023 to 2029.
United States market for Structural Heart Disease Interventional Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Structural Heart Disease Interventional Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Structural Heart Disease Interventional Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Structural Heart Disease Interventional Therapy players cover Abbott Structural Heart, philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc. and boston scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Structural heart disease refers to any abnormality in the structure of the heart, any disease involving the structure of the heart and great vessels
LPI (LP Information)’ newest research report, the “Structural Heart Disease Interventional Therapy Industry Forecast” looks at past sales and reviews total world Structural Heart Disease Interventional Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Structural Heart Disease Interventional Therapy sales for 2023 through 2029. With Structural Heart Disease Interventional Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Structural Heart Disease Interventional Therapy industry.
This Insight Report provides a comprehensive analysis of the global Structural Heart Disease Interventional Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Structural Heart Disease Interventional Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Structural Heart Disease Interventional Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Structural Heart Disease Interventional Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Structural Heart Disease Interventional Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Structural Heart Disease Interventional Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Equipment
Consumables
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Structural Heart
philips
Japen Lifeline
Neovasc
Append Medical
Transverse Medical
Cardiomech
Thubrikar Aortic Valve Inc.
boston scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova PLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Structural Heart Disease Interventional Therapy market?
What factors are driving Structural Heart Disease Interventional Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Structural Heart Disease Interventional Therapy market opportunities vary by end market size?
How does Structural Heart Disease Interventional Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Structural Heart Disease Interventional Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Structural Heart Disease Interventional Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Structural Heart Disease Interventional Therapy by Country/Region, 2018, 2022 & 2029
2.2 Structural Heart Disease Interventional Therapy Segment by Type
2.2.1 Equipment
2.2.2 Consumables
2.3 Structural Heart Disease Interventional Therapy Sales by Type
2.3.1 Global Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Structural Heart Disease Interventional Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Structural Heart Disease Interventional Therapy Sale Price by Type (2018-2023)
2.4 Structural Heart Disease Interventional Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Structural Heart Disease Interventional Therapy Sales by Application
2.5.1 Global Structural Heart Disease Interventional Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Structural Heart Disease Interventional Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Structural Heart Disease Interventional Therapy Sale Price by Application (2018-2023)
3 Global Structural Heart Disease Interventional Therapy by Company
3.1 Global Structural Heart Disease Interventional Therapy Breakdown Data by Company
3.1.1 Global Structural Heart Disease Interventional Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Structural Heart Disease Interventional Therapy Sales Market Share by Company (2018-2023)
3.2 Global Structural Heart Disease Interventional Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Structural Heart Disease Interventional Therapy Revenue by Company (2018-2023)
3.2.2 Global Structural Heart Disease Interventional Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Structural Heart Disease Interventional Therapy Sale Price by Company
3.4 Key Manufacturers Structural Heart Disease Interventional Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Structural Heart Disease Interventional Therapy Product Location Distribution
3.4.2 Players Structural Heart Disease Interventional Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Structural Heart Disease Interventional Therapy by Geographic Region
4.1 World Historic Structural Heart Disease Interventional Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Structural Heart Disease Interventional Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Structural Heart Disease Interventional Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Structural Heart Disease Interventional Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Structural Heart Disease Interventional Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Structural Heart Disease Interventional Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Structural Heart Disease Interventional Therapy Sales Growth
4.4 APAC Structural Heart Disease Interventional Therapy Sales Growth
4.5 Europe Structural Heart Disease Interventional Therapy Sales Growth
4.6 Middle East & Africa Structural Heart Disease Interventional Therapy Sales Growth
5 Americas
5.1 Americas Structural Heart Disease Interventional Therapy Sales by Country
5.1.1 Americas Structural Heart Disease Interventional Therapy Sales by Country (2018-2023)
5.1.2 Americas Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023)
5.2 Americas Structural Heart Disease Interventional Therapy Sales by Type
5.3 Americas Structural Heart Disease Interventional Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Structural Heart Disease Interventional Therapy Sales by Region
6.1.1 APAC Structural Heart Disease Interventional Therapy Sales by Region (2018-2023)
6.1.2 APAC Structural Heart Disease Interventional Therapy Revenue by Region (2018-2023)
6.2 APAC Structural Heart Disease Interventional Therapy Sales by Type
6.3 APAC Structural Heart Disease Interventional Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Structural Heart Disease Interventional Therapy by Country
7.1.1 Europe Structural Heart Disease Interventional Therapy Sales by Country (2018-2023)
7.1.2 Europe Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023)
7.2 Europe Structural Heart Disease Interventional Therapy Sales by Type
7.3 Europe Structural Heart Disease Interventional Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Structural Heart Disease Interventional Therapy by Country
8.1.1 Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Type
8.3 Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Structural Heart Disease Interventional Therapy
10.3 Manufacturing Process Analysis of Structural Heart Disease Interventional Therapy
10.4 Industry Chain Structure of Structural Heart Disease Interventional Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Structural Heart Disease Interventional Therapy Distributors
11.3 Structural Heart Disease Interventional Therapy Customer
12 World Forecast Review for Structural Heart Disease Interventional Therapy by Geographic Region
12.1 Global Structural Heart Disease Interventional Therapy Market Size Forecast by Region
12.1.1 Global Structural Heart Disease Interventional Therapy Forecast by Region (2024-2029)
12.1.2 Global Structural Heart Disease Interventional Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Structural Heart Disease Interventional Therapy Forecast by Type
12.7 Global Structural Heart Disease Interventional Therapy Forecast by Application
13 Key Players Analysis
13.1 Abbott Structural Heart
13.1.1 Abbott Structural Heart Company Information
13.1.2 Abbott Structural Heart Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.1.3 Abbott Structural Heart Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Structural Heart Main Business Overview
13.1.5 Abbott Structural Heart Latest Developments
13.2 philips
13.2.1 philips Company Information
13.2.2 philips Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.2.3 philips Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 philips Main Business Overview
13.2.5 philips Latest Developments
13.3 Japen Lifeline
13.3.1 Japen Lifeline Company Information
13.3.2 Japen Lifeline Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.3.3 Japen Lifeline Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Japen Lifeline Main Business Overview
13.3.5 Japen Lifeline Latest Developments
13.4 Neovasc
13.4.1 Neovasc Company Information
13.4.2 Neovasc Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.4.3 Neovasc Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Neovasc Main Business Overview
13.4.5 Neovasc Latest Developments
13.5 Append Medical
13.5.1 Append Medical Company Information
13.5.2 Append Medical Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.5.3 Append Medical Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Append Medical Main Business Overview
13.5.5 Append Medical Latest Developments
13.6 Transverse Medical
13.6.1 Transverse Medical Company Information
13.6.2 Transverse Medical Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.6.3 Transverse Medical Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Transverse Medical Main Business Overview
13.6.5 Transverse Medical Latest Developments
13.7 Cardiomech
13.7.1 Cardiomech Company Information
13.7.2 Cardiomech Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.7.3 Cardiomech Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cardiomech Main Business Overview
13.7.5 Cardiomech Latest Developments
13.8 Thubrikar Aortic Valve Inc.
13.8.1 Thubrikar Aortic Valve Inc. Company Information
13.8.2 Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.8.3 Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Thubrikar Aortic Valve Inc. Main Business Overview
13.8.5 Thubrikar Aortic Valve Inc. Latest Developments
13.9 boston scientific
13.9.1 boston scientific Company Information
13.9.2 boston scientific Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.9.3 boston scientific Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 boston scientific Main Business Overview
13.9.5 boston scientific Latest Developments
13.10 Edwards Lifesciences Corporation
13.10.1 Edwards Lifesciences Corporation Company Information
13.10.2 Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.10.3 Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Edwards Lifesciences Corporation Main Business Overview
13.10.5 Edwards Lifesciences Corporation Latest Developments
13.11 Biomerics
13.11.1 Biomerics Company Information
13.11.2 Biomerics Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.11.3 Biomerics Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biomerics Main Business Overview
13.11.5 Biomerics Latest Developments
13.12 LivaNova PLC
13.12.1 LivaNova PLC Company Information
13.12.2 LivaNova PLC Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
13.12.3 LivaNova PLC Structural Heart Disease Interventional Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 LivaNova PLC Main Business Overview
13.12.5 LivaNova PLC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Structural Heart Disease Interventional Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Structural Heart Disease Interventional Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Equipment
Table 4. Major Players of Consumables
Table 5. Global Structural Heart Disease Interventional Therapy Sales by Type (2018-2023) & (K Units)
Table 6. Global Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
Table 7. Global Structural Heart Disease Interventional Therapy Revenue by Type (2018-2023) & ($ million)
Table 8. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Structural Heart Disease Interventional Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Structural Heart Disease Interventional Therapy Sales by Application (2018-2023) & (K Units)
Table 11. Global Structural Heart Disease Interventional Therapy Sales Market Share by Application (2018-2023)
Table 12. Global Structural Heart Disease Interventional Therapy Revenue by Application (2018-2023)
Table 13. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Application (2018-2023)
Table 14. Global Structural Heart Disease Interventional Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Structural Heart Disease Interventional Therapy Sales by Company (2018-2023) & (K Units)
Table 16. Global Structural Heart Disease Interventional Therapy Sales Market Share by Company (2018-2023)
Table 17. Global Structural Heart Disease Interventional Therapy Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Company (2018-2023)
Table 19. Global Structural Heart Disease Interventional Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Structural Heart Disease Interventional Therapy Producing Area Distribution and Sales Area
Table 21. Players Structural Heart Disease Interventional Therapy Products Offered
Table 22. Structural Heart Disease Interventional Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Structural Heart Disease Interventional Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Structural Heart Disease Interventional Therapy Sales Market Share Geographic Region (2018-2023)
Table 27. Global Structural Heart Disease Interventional Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Structural Heart Disease Interventional Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Structural Heart Disease Interventional Therapy Sales Market Share by Country/Region (2018-2023)
Table 31. Global Structural Heart Disease Interventional Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Structural Heart Disease Interventional Therapy Sales by Country (2018-2023) & (K Units)
Table 34. Americas Structural Heart Disease Interventional Therapy Sales Market Share by Country (2018-2023)
Table 35. Americas Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Structural Heart Disease Interventional Therapy Revenue Market Share by Country (2018-2023)
Table 37. Americas Structural Heart Disease Interventional Therapy Sales by Type (2018-2023) & (K Units)
Table 38. Americas Structural Heart Disease Interventional Therapy Sales by Application (2018-2023) & (K Units)
Table 39. APAC Structural Heart Disease Interventional Therapy Sales by Region (2018-2023) & (K Units)
Table 40. APAC Structural Heart Disease Interventional Therapy Sales Market Share by Region (2018-2023)
Table 41. APAC Structural Heart Disease Interventional Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Structural Heart Disease Interventional Therapy Revenue Market Share by Region (2018-2023)
Table 43. APAC Structural Heart Disease Interventional Therapy Sales by Type (2018-2023) & (K Units)
Table 44. APAC Structural Heart Disease Interventional Therapy Sales by Application (2018-2023) & (K Units)
Table 45. Europe Structural Heart Disease Interventional Therapy Sales by Country (2018-2023) & (K Units)
Table 46. Europe Structural Heart Disease Interventional Therapy Sales Market Share by Country (2018-2023)
Table 47. Europe Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Structural Heart Disease Interventional Therapy Revenue Market Share by Country (2018-2023)
Table 49. Europe Structural Heart Disease Interventional Therapy Sales by Type (2018-2023) & (K Units)
Table 50. Europe Structural Heart Disease Interventional Therapy Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Structural Heart Disease Interventional Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Structural Heart Disease Interventional Therapy Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Structural Heart Disease Interventional Therapy Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Structural Heart Disease Interventional Therapy
Table 58. Key Market Challenges & Risks of Structural Heart Disease Interventional Therapy
Table 59. Key Industry Trends of Structural Heart Disease Interventional Therapy
Table 60. Structural Heart Disease Interventional Therapy Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Structural Heart Disease Interventional Therapy Distributors List
Table 63. Structural Heart Disease Interventional Therapy Customer List
Table 64. Global Structural Heart Disease Interventional Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Structural Heart Disease Interventional Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Structural Heart Disease Interventional Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Structural Heart Disease Interventional Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Structural Heart Disease Interventional Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Structural Heart Disease Interventional Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Structural Heart Disease Interventional Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Structural Heart Disease Interventional Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Structural Heart Disease Interventional Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Structural Heart Disease Interventional Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Structural Heart Disease Interventional Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Structural Heart Disease Interventional Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Structural Heart Disease Interventional Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Structural Heart Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Structural Heart Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 80. Abbott Structural Heart Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Structural Heart Main Business
Table 82. Abbott Structural Heart Latest Developments
Table 83. philips Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. philips Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 85. philips Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. philips Main Business
Table 87. philips Latest Developments
Table 88. Japen Lifeline Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Japen Lifeline Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 90. Japen Lifeline Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Japen Lifeline Main Business
Table 92. Japen Lifeline Latest Developments
Table 93. Neovasc Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. Neovasc Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 95. Neovasc Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Neovasc Main Business
Table 97. Neovasc Latest Developments
Table 98. Append Medical Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Append Medical Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 100. Append Medical Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Append Medical Main Business
Table 102. Append Medical Latest Developments
Table 103. Transverse Medical Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Transverse Medical Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 105. Transverse Medical Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Transverse Medical Main Business
Table 107. Transverse Medical Latest Developments
Table 108. Cardiomech Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Cardiomech Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 110. Cardiomech Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Cardiomech Main Business
Table 112. Cardiomech Latest Developments
Table 113. Thubrikar Aortic Valve Inc. Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 115. Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Thubrikar Aortic Valve Inc. Main Business
Table 117. Thubrikar Aortic Valve Inc. Latest Developments
Table 118. boston scientific Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. boston scientific Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 120. boston scientific Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. boston scientific Main Business
Table 122. boston scientific Latest Developments
Table 123. Edwards Lifesciences Corporation Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 125. Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Edwards Lifesciences Corporation Main Business
Table 127. Edwards Lifesciences Corporation Latest Developments
Table 128. Biomerics Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 129. Biomerics Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 130. Biomerics Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Biomerics Main Business
Table 132. Biomerics Latest Developments
Table 133. LivaNova PLC Basic Information, Structural Heart Disease Interventional Therapy Manufacturing Base, Sales Area and Its Competitors
Table 134. LivaNova PLC Structural Heart Disease Interventional Therapy Product Portfolios and Specifications
Table 135. LivaNova PLC Structural Heart Disease Interventional Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. LivaNova PLC Main Business
Table 137. LivaNova PLC Latest Developments
List of Figures
Figure 1. Picture of Structural Heart Disease Interventional Therapy
Figure 2. Structural Heart Disease Interventional Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Structural Heart Disease Interventional Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Structural Heart Disease Interventional Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Structural Heart Disease Interventional Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Equipment
Figure 10. Product Picture of Consumables
Figure 11. Global Structural Heart Disease Interventional Therapy Sales Market Share by Type in 2022
Figure 12. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Type (2018-2023)
Figure 13. Structural Heart Disease Interventional Therapy Consumed in Hospital
Figure 14. Global Structural Heart Disease Interventional Therapy Market: Hospital (2018-2023) & (K Units)
Figure 15. Structural Heart Disease Interventional Therapy Consumed in Clinic
Figure 16. Global Structural Heart Disease Interventional Therapy Market: Clinic (2018-2023) & (K Units)
Figure 17. Structural Heart Disease Interventional Therapy Consumed in Others
Figure 18. Global Structural Heart Disease Interventional Therapy Market: Others (2018-2023) & (K Units)
Figure 19. Global Structural Heart Disease Interventional Therapy Sales Market Share by Application (2022)
Figure 20. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Application in 2022
Figure 21. Structural Heart Disease Interventional Therapy Sales Market by Company in 2022 (K Units)
Figure 22. Global Structural Heart Disease Interventional Therapy Sales Market Share by Company in 2022
Figure 23. Structural Heart Disease Interventional Therapy Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Company in 2022
Figure 25. Global Structural Heart Disease Interventional Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Structural Heart Disease Interventional Therapy Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Structural Heart Disease Interventional Therapy Sales 2018-2023 (K Units)
Figure 28. Americas Structural Heart Disease Interventional Therapy Revenue 2018-2023 ($ Millions)
Figure 29. APAC Structural Heart Disease Interventional Therapy Sales 2018-2023 (K Units)
Figure 30. APAC Structural Heart Disease Interventional Therapy Revenue 2018-2023 ($ Millions)
Figure 31. Europe Structural Heart Disease Interventional Therapy Sales 2018-2023 (K Units)
Figure 32. Europe Structural Heart Disease Interventional Therapy Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Structural Heart Disease Interventional Therapy Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Structural Heart Disease Interventional Therapy Revenue 2018-2023 ($ Millions)
Figure 35. Americas Structural Heart Disease Interventional Therapy Sales Market Share by Country in 2022
Figure 36. Americas Structural Heart Disease Interventional Therapy Revenue Market Share by Country in 2022
Figure 37. Americas Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
Figure 38. Americas Structural Heart Disease Interventional Therapy Sales Market Share by Application (2018-2023)
Figure 39. United States Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Structural Heart Disease Interventional Therapy Sales Market Share by Region in 2022
Figure 44. APAC Structural Heart Disease Interventional Therapy Revenue Market Share by Regions in 2022
Figure 45. APAC Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
Figure 46. APAC Structural Heart Disease Interventional Therapy Sales Market Share by Application (2018-2023)
Figure 47. China Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Structural Heart Disease Interventional Therapy Sales Market Share by Country in 2022
Figure 55. Europe Structural Heart Disease Interventional Therapy Revenue Market Share by Country in 2022
Figure 56. Europe Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
Figure 57. Europe Structural Heart Disease Interventional Therapy Sales Market Share by Application (2018-2023)
Figure 58. Germany Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Structural Heart Disease Interventional Therapy Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Market Share by Application (2018-2023)
Figure 67. Egypt Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Structural Heart Disease Interventional Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Structural Heart Disease Interventional Therapy in 2022
Figure 73. Manufacturing Process Analysis of Structural Heart Disease Interventional Therapy
Figure 74. Industry Chain Structure of Structural Heart Disease Interventional Therapy
Figure 75. Channels of Distribution
Figure 76. Global Structural Heart Disease Interventional Therapy Sales Market Forecast by Region (2024-2029)
Figure 77. Global Structural Heart Disease Interventional Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Structural Heart Disease Interventional Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Structural Heart Disease Interventional Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Structural Heart Disease Interventional Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Structural Heart Disease Interventional Therapy Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の構造的心疾患介入療法市場予測 2023年-2029年] (コード：LP23DC04733)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の構造的心疾患介入療法市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の神経介入治療用経路製品市場予測 2023年-2029年
  • 世界の超音波骨折治療装置市場予測 2023年-2029年
  • 世界の人工心肺装置人工肺市場予測 2023年-2029年
  • 世界の鼓動心臓パッチ市場予測 2023年-2029年
  • 世界のマイクロニードル治療器市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆